Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Illinois Tool Works Inc. (ITW) vs Global X Uranium ETF (URA) Price & Performance

Illinois Tool Works Inc.Trade
Global X Uranium ETFTrade

Price performance (Past 24H)

Key statistics

Illinois Tool Works Inc. vs Global X Uranium ETF — how do they compare? Illinois Tool Works Inc. trades at $264.31 (market cap $74.38B), while Global X Uranium ETF trades at $38.68 (market cap $5.48B). The key difference: Illinois Tool Works Inc. is far larger — about 13.6× Global X Uranium ETF's market cap, and Illinois Tool Works Inc. pays a 2.63% dividend while Global X Uranium ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illinois Tool Works Inc. for 67 Days and Global X Uranium ETF for 62 Days on average.

ITWURA
Market Cap
$74.38B$5.48B
Volume
1,125,4775,287,170
Sector
IndustrialsCommodities - Metals/Agriculture
52-Week High
$299.60$61.81
52-Week Low
$241.07$37.52
Typical Hold Time
67 Days62 Days
Enterprise Value
$83.23B—
Dividend Yield
2.63%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Illinois Tool Works Inc.

ITW trades at $261.15, down 2.24% on the day, with technical indicators showing bearish momentum as the stock tests support near $261. The company maintains strong fundamentals with a 19.39% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights ITW's dividend increase to $1.72 per share, reinforcing its status as a Dividend King with 59 years of consecutive increases.

The outlook remains mixed with solid profitability offset by bearish technicals. Upside potential exists toward the $276.86 analyst consensus target, but investors face headwinds from weak technical momentum and mixed analyst sentiment where only 21% recommend buying. Key risks include debt levels rising to 55.54% of assets and exposure to cyclical industrial demand.

Global X Uranium ETF

URA is trading at $38.58, down 3.38% today amid bearish technical signals. The ETF shows negative momentum with all 13 moving averages signaling sell. Recent news highlights nuclear energy's growth potential, including US-Saudi atomic deals and AI-driven power demand, though uranium miners face price volatility. The fund provides diversified exposure to uranium miners, utilities, and nuclear infrastructure companies.

Outlook remains cautiously optimistic given nuclear energy's structural growth drivers, but near-term pressure persists from uranium price fluctuations. Key risks include commodity volatility and regulatory uncertainty, while catalysts include government nuclear investments and AI power demand. The current technical weakness may present entry opportunities for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ITW
75% Buy25% Sell
Avg holding period · 67 Days
URA
94% Buy6% Sell
Avg holding period · 62 Days

Top news

Latest headlines on both assets

About Illinois Tool Works Inc.

Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.

Read more on ITW →

About Global X Uranium ETF

URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.

Read more on URA →